| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | AMPK signaling pathway 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| 2 | Bile secretion 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| 3 | Calcium signaling pathway 2 genes, 3 drugs (DrugBank), 10 diseases shown |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| [2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| 4 | cAMP signaling pathway 1 gene, 3 drugs (DrugBank), 10 diseases shown |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| 5 | cGMP-PKG signaling pathway 5 genes, 4 drugs (DrugBank), 12 diseases shown |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| [2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 6 | Circadian entrainment 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 7 | Complement and coagulation cascades 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] F10 |
D09710 |
Edoxaban |
[2] 46, 88 |
| 8 | Fluid shear stress and atherosclerosis 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] NQO1 |
D00564 |
Warfarin |
[10] 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 9 | Gap junction 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 10 | Hepatocellular carcinoma 1 gene, 1 drug (DrugBank), 10 diseases shown |
[1] NQO1 |
D00564 |
Warfarin |
[10] 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 11 | Long-term depression 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 12 | Melanogenesis 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| 13 | Metabolic pathways 6 genes, 3 drugs (DrugBank), 23 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| [2] NQO1, VKORC1 |
D00564 |
Warfarin |
[10] 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 14 | Neuroactive ligand-receptor interaction 3 genes, 5 drugs (DrugBank), 11 diseases shown |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| [2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| [1] PTGIR |
D09994 |
Selexipag |
[5] 51, 70, 84, 86, 88 |
| D06213 |
Treprostinil |
[5] 51, 84, 85, 86, 88 |
| 15 | Oxytocin signaling pathway 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 16 | Pathways in cancer 3 genes, 4 drugs (DrugBank), 17 diseases shown |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| [2] EDNRA, EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| [1] NQO1 |
D00564 |
Warfarin |
[10] 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 17 | Platelet activation 4 genes, 3 drugs (DrugBank), 8 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] PTGIR |
D09994 |
Selexipag |
[5] 51, 70, 84, 86, 88 |
| D06213 |
Treprostinil |
[5] 51, 84, 85, 86, 88 |
| 18 | Purine metabolism 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 19 | Relaxin signaling pathway 1 gene, 2 drugs (DrugBank), 10 diseases shown |
[1] EDNRB |
D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| 20 | Renin secretion 4 genes, 4 drugs (DrugBank), 12 diseases shown |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 21 | Salivary secretion 3 genes, 1 drug (DrugBank), 6 diseases shown |
[3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| 22 | Terpenoid backbone biosynthesis 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] HMGCR |
D00887 |
Atorvastatin |
[17] 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 |
| D07474 |
| 23 | Ubiquinone and other terpenoid-quinone biosynthesis 2 genes, 1 drug (DrugBank), 10 diseases shown |
[2] NQO1, VKORC1 |
D00564 |
Warfarin |
[10] 6, 8, 13, 19, 46, 49, 66, 85, 88, 96 |
| D01280 |
| D08682 |
| 24 | Vascular smooth muscle contraction 5 genes, 6 drugs (DrugBank), 13 diseases shown |
[1] EDNRA |
D07077 |
Ambrisentan |
[6] 51, 84, 85, 86, 88, 211 |
| D01227 |
Bosentan |
[10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |
| D10135 |
Macitentan |
[5] 51, 85, 86, 88, 210 |
| [3] GUCY1A1, GUCY1A2, GUCY1B1 |
D09572 |
Riociguat |
[6] 51, 84, 86, 88, 225, 299 |
| [1] PTGIR |
D09994 |
Selexipag |
[5] 51, 70, 84, 86, 88 |
| D06213 |
Treprostinil |
[5] 51, 84, 85, 86, 88 |